Kentaro Fujiwara, Atsushi B Tsuji, Hitomi Sudo, Aya Sugyo, Takao Hamakubo, Tatsuya Higashi. The tyrosine kinase inhibitor nintedanib enhances the efficacy of 90 Y-labeled B5209B radioimmunotherapy targeting ROBO1 without increased toxicity in small-cell lung cancer xenograft mice. Nuclear medicine communications. 2024. 45. 1. 68-76
Honoka Obata, Atsushi B Tsuji, Hitomi Sudo, Aya Sugyo, Kaori Hashiya, Hayato Ikeda, Masatoshi Itoh, Katsuyuki Minegishi, Kotaro Nagatsu, Mikako Ogawa, et al. Novel Auger-Electron-Emitting 191Pt-Labeled Pyrrole-Imidazole Polyamide Targeting MYCN Increases Cytotoxicity and Cytosolic dsDNA Granules in MYCN-Amplified Neuroblastoma. Pharmaceuticals (Basel, Switzerland). 2023. 16. 11
Honoka Obata, Atsushi B Tsuji, Hitomi Sudo, Aya Sugyo, Katsuyuki Minegishi, Kotaro Nagatsu, Mikako Ogawa, Ming-Rong Zhang. Precise quantitative evaluation of pharmacokinetics of cisplatin using a radio-platinum tracer in tumor-bearing mice. Nuclear medicine communications. 2022. 43. 11. 1121-1127
須藤 仁美, 辻 厚至, 須堯 綾, 小泉 満, 黒澤 仁, 黒澤 良和, 佐賀 恒夫, 東 達也. 免疫抑制に関与するCD73の発現の非侵襲的イメージング(Development of a noninvasive imaging technique to detect the expression of CD73 mediating immunosuppression in cancer). 日本癌学会総会記事. 2018. 77回. 804-804
Ryuichi Nishii, Tsuneo Saga, Hitomi Sudo, Takashi Togawa, Keiichiro Yoshinaga, Tatsuya Higashi. Assessment of 4DST uptake and Ki-67 index in patients with lung tumor in comparison with FDG uptake. JOURNAL OF NUCLEAR MEDICINE. 2017. 58
Chie Suzuki, Atsushi B. Tsuji, Koichi Kato, Hitomi Sudo, Ming-Rong Zhang, Yasushi Arano, Tsuneo Saga. Synthesis and biological evaluation of 2-amino-2-[C-11]methyl-butanoic acid as a potential PET probe for tumor imaging. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2015. 58. S305-S305
